Pegfilgrastim

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Peripheral Blood Stem Cell Transplantation

Drug Information

Target Indication

Peripheral Blood Stem Cell Transplantation

Clinical Trial

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

KYKOY

Kyowa Kirin Pharmaceutical Development

Related Pipeline

Anemia

X-Linked Hypophosphatemia

X-linked Hypophosphatemia (XLH)

Disseminated Intravascular Coagulation (DIC)

Hyperphosphatemia

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts